Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss.
Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in